RANI THERAPEUTICS HOLDINGS, INC.

Transcripts Rani Therapeutics Holdings, Inc.

Equities

RANI

US7530181004

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
6.68 ^USD	+1.83%		-5.52%	+101.20%

Mar. 27	Canaccord Genuity Adjusts Rani Therapeutics Price Target to $9 From $21, Maintains Buy Rating	MT
Mar. 25	HC Wainwright Adjusts Price Target on Rani Therapeutics to $12 From $16, Keeps Buy Rating	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Rani Therapeutics Holdings, Inc., Q4 2023 Earnings Call, Mar 20, 2024	Mar. 20
Transcript : Rani Therapeutics Holdings, Inc. - Special Call	Feb. 05
Transcript : Rani Therapeutics Holdings, Inc., Q4 2022 Earnings Call, Mar 22, 2023	23-03-22
Transcript : Rani Therapeutics Holdings, Inc. - Special Call	22-12-06
Transcript : Rani Therapeutics Holdings, Inc. Presents at Needham 21st Annual Healthcare Conference, Apr-14-2022 03:45 PM	22-04-14
Transcript : Rani Therapeutics Holdings, Inc., Q4 2021 Earnings Call, Mar 29, 2022	22-03-29
Rani Therapeutics Holdings, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer